amikacin has been researched along with cefotaxime in 175 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 63 (36.00) | 18.7374 |
| 1990's | 24 (13.71) | 18.2507 |
| 2000's | 56 (32.00) | 29.6817 |
| 2010's | 28 (16.00) | 24.3611 |
| 2020's | 4 (2.29) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YG; Du, XX; Li, LJ; Shen, P; Wei, ZQ; Yu, YS | 1 |
| Ko, WC; Tsai, SH; Wu, JJ; Yan, JJ | 1 |
| Correa, A; Kattan, JN; Lolans, K; Lopez, JA; Quinn, JP; Villegas, MV | 1 |
| Caniça, M; Ferreira, E; Leitão, J; Manageiro, V; Mendonça, N | 1 |
| Cauda, R; Citton, R; D'Inzeo, T; Fadda, G; Fiori, B; Montuori, E; Posteraro, B; Sanguinetti, M; Spanu, T; Trecarichi, EM; Tumbarello, M | 1 |
| Bonomo, RA; Endimiani, A; Hujer, AM; Hujer, KM; Luzzaro, F; Mantengoli, E; Migliavacca, R; Pagani, L; Rossolini, GM; Toniolo, A | 1 |
| Avlami, A; Daikos, GL; Katsilambros, N; Kosmidis, C; Petrikkos, G; Psychogiou, M; Stefanou, I; Tassios, PT; Vasilakopoulou, A | 1 |
| Bille, J; Lartigue, MF; Nordmann, P; Poirel, L; Wenger, A; Zinsius, C | 1 |
| Courvalin, P; Galimand, M; Périchon, B | 1 |
| Afkou, Z; Ikonomidis, A; Labrou, M; Maniatis, AN; Pournaras, S; Sofianou, D; Tsakris, A | 1 |
| Beceiro, A; Bou, G; Canle, D; Fernández, A; Lasa, I; Latasa, C; Mallo, S; Molina, F; Pérez, A; Pérez, S; Poza, M; Tomás, Mdel M; Villanueva, R | 1 |
| Fung, CP; Hsieh, YP; Hu, WS; Lin, JF; Liu, CP; Yao, SM | 1 |
| Liu, Y; Shi, W; Wang, M; Wu, S; Xu, X; Ye, X; Zhang, Y | 1 |
| Adams-Haduch, JM; Doi, Y; Paterson, DL | 1 |
| Arakawa, Y; Suzuki, S; Wachino, J; Yamane, K | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Apisarnthanarak, A; Kiratisin, P; Laesripa, C; Saifon, P | 1 |
| Badur, S; Cagatay, AA; Carrër, A; Eraksoy, H; Nordmann, P; Poirel, L | 1 |
| Albertí, S; Beceiro, A; Bou, G; Garau, M; Gutiérrez, O; Juan, C; Oliver, A; Pérez, JL | 1 |
| Cattoir, V; Nordmann, P; Poirel, L | 1 |
| Chen, H; Chen, M; Wang, H; Yang, H; Yang, Q | 1 |
| Berçot, B; Nordmann, P; Poirel, L | 1 |
| Chang, FY; Chen, JH; Fung, CP; Lai, YK; Lin, CJ; Lin, JC; Ma, L; Siu, LK | 1 |
| Chen, Z; Deng, Y; Huang, L; Liu, J; Lü, D; Ma, J; Wang, M; Wang, X; Xu, X; Zeng, Z; Zhang, Y | 1 |
| Andlovic, A; Jeverica, S; Karisik, E; Koren, S; Krizan-Hergouth, V; Livermore, DM; Mesko Meglic, K; Müller-Premru, M; Palepou, MF; Pike, R; Seme, K; Woodford, N | 1 |
| Baptista, BC; Correia, JD; da Fonseca, JD; Martínez-Martínez, L; Pomba, C | 1 |
| Bell, JM; Castanheira, M; Jones, RN; Mathai, D; Turnidge, JD | 1 |
| Baraniak, A; Bedenic, B; Fiett, J; Gniadkowski, M; Jajic-Bencic, I; Literacka, E; Tonkic, M | 1 |
| Duljasz, W; Gniadkowski, M; Jebelean, C; Sitter, S; Wojna, A | 1 |
| Gales, AC; Nordmann, P; Picão, RC; Poirel, L | 1 |
| Guo, Q; Hooper, DC; Wang, M; Wang, X; Wu, S; Xu, X; Ye, X | 1 |
| Badal, RE; Bouchillon, SK; Hawser, SP; Hoban, DJ; Hsueh, PR; Paterson, DL | 1 |
| Baraniak, A; Fiett, J; Filczak, K; Gniadkowski, M; Herda, M; Hryniewicz, W; Izdebski, R; Kern-Zdanowicz, I; Łopaciuk, U | 1 |
| Carattoli, A; Ellington, MJ; Karisik, E; Livermore, DM; Underwood, A; Woodford, N | 1 |
| Brémont, S; Courvalin, P; Daurel, C; Fiant, AL; Leclercq, R | 1 |
| Chen, H; Chen, M; Sun, H; Wang, H; Xu, Y; Yang, Q | 1 |
| Girlich, D; Nordmann, P; Poirel, L | 1 |
| Courvalin, P; Coyne, S; Guigon, G; Périchon, B | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Dunman, PM; Hood, MI; Jacobs, AC; Sayood, K; Skaar, EP | 1 |
| Aquino, EE; León, CF; Otero, DM; Robledo, IE; Santana, JL; Santé, MI; Vázquez, GJ | 1 |
| Beceiro, A; Bou, G; Doumith, M; Livermore, DM; Tomás, M; Turton, JF; Warner, M; Woodford, N | 1 |
| Badal, RE; Baquero, F; Bouchillon, SK; Cantón, R; Hawser, SP; Hoban, DJ | 1 |
| Badal, RE; Bouchillon, SK; DiPersio, J; Hawser, SP; Hoban, DJ; Labombardi, VJ | 1 |
| Asai, Y; Fujii, N; Maekawa, K; Mizuno, H; Mori, K; Sakawaki, E; Sawamoto, K; Tanno, K; Uemura, S; Yokota, S | 1 |
| Bogaerts, P; Buvens, G; Glupczynski, Y; Lauwers, S; Piérard, D | 1 |
| Hamprecht, A; Higgins, PG; Schneiders, T; Seifert, H | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Arya, G; Dalal, P; Kaur, M; Nimesh, S; Salunke, DB; Singh, R; Singla, P | 1 |
| Björkling, F; Bonke, G; Franzyk, H; Hansen, AM; Hogendorf, WFJ; Kongstad, KT; Nielsen, J; Nielsen, PE; Tomczak, M; Urbas, M; Zabicka, D | 1 |
| Kasatkina, IV; Makarovskaia, LN; Shcherbaniuk, AI; Zurabian, VA | 1 |
| Kasatkina, IV; Makarovskaia, LN; Shcherbaniuk, AI | 1 |
| Bhana, RH; Coovadia, YM; George, RC; Hafferjee, IE; Hutchinson, GR; Johnson, AP | 1 |
| da Silva, FC | 1 |
| Bryant, RE; Fox, K; Morthland, VH; Oh, G | 1 |
| Beningfield, SJ; Immelman, EJ; Lourens, S; Matley, PJ | 1 |
| Havlik, I; Lipman, J; Marik, PE; Monteagudo, FS | 1 |
| Beaucaire, G; Beuscart, C; Caillaux, M; Chidiac, C; Karp, P; Leroy, O | 1 |
| Koenig, G; Simon, DM; Trenholme, GM | 1 |
| Gedikoğlu, S; Göral, G; Helvaci, S; Kiliçturgay, K | 1 |
| Bazin, C; Deboscker, Y; Fourrier, F; Moulront, S; Mouton, Y; Philippon, A; Socolovsky, C; Suinat, JL; Tondriaux, A | 1 |
| Adhikari, M; Coovadia, YM; Mayosi, B; Solwa, Z; van den Ende, J | 1 |
| Aydin, M; Dervişoğlu, AA; Unal, S | 1 |
| Abumelha, A; al-Fadil, M; al-Mulhim, I; Sumer, T | 1 |
| Albayrak, D; Taşdemir, HA | 1 |
| Agusti Vidal, A; Almela, M; de Celis, R; Deulofeu, R; Marco, F; Rabinad, E; Rodriguez-Roisin, R; Torres, A | 1 |
| Bodunkova, LE; Ivanitskaia, LP; Kudinova, MK; Samoĭlova, LN; Viadro, MM | 1 |
| Insler, MS; Rootman, DS; Wolfley, DE | 1 |
| Evagelopoulou, V; Giamarellou, H; Lelekis, M | 1 |
| Ansquer, M; Brun-Buisson, C; Duval, J; Legrand, P; Montravers, F; Philippon, A | 1 |
| Rahal, JJ; Simberkoff, MS | 1 |
| Aujard, Y; Bingen, E; Lambert-Zechovsky, N; Lemer, G; Mariani, P; Mathieu, H; Sauzeau, C | 1 |
| Pappo, M; Piguet, H | 1 |
| Giamarellou, H | 1 |
| Bamberger, DM; Fasching, CE; Gerding, DN; Moody, JA; Peterson, LR | 1 |
| Andersen, GE; Colding, H; Goldstein, K | 1 |
| Clavijo, E; García Luque, IG; Nogales, MC; Perea, EJ | 1 |
| Borrego Galán, JC; Chimpén Ruiz, VA; Mejía Molina, P; Zurdo García, JR | 1 |
| Colucci, A; Coniglio, M; Girardi, F; Guarini, A; Iaculli, L; Liso, V; Pavone, V; Specchia, G | 1 |
| Munro, R; Rawlinson, W; Sorrell, T | 1 |
| Almela, M; Carreras, E; Grañena, A; Jiménez de Anta, MT; Marín, P; Rozman, C; Valls, A | 1 |
| Auboyer, C; Becq-Giraudon, B; Bertrand, P; Buré, A; Carbon, C; Gallais, H; Motin, JP; Mouton, Y; Vachon, F; Wasmer, JM | 1 |
| Dámaso, D; Daza, RM; Martínez-Martínez, L; Mendaza, P; Mesa, E; Portero, F; Sánchez-Moreno, MP | 1 |
| Blaysat, G; Gardembas-Pain, M; Lemeland, JF; Tron, P; Vannier, JP | 1 |
| Husson, MO; Izard, D; Leclerc, H | 2 |
| Hattori, M; Kaneko, Y; Kumai, R; Maseki, N; Sakurai, M; Sampi, K | 1 |
| Fasching, CE; Gerding, DN; Peterson, LR | 1 |
| Gaya, H; Glauser, MP; Klastersky, J; Schimpff, SC; Zinner, SH | 1 |
| Bouillet, L; Husson, MO; Izard, D; Leclerc, H | 1 |
| Colomo-Muñúzuri, AC; Moreno-Martínez, JA; Sánchez-Sánchez, C; Santos-Preciado, JI | 1 |
| Acar, JF; Bleriot, JP; Goldstein, FW; Menard, R | 1 |
| Holloway, WJ | 1 |
| Fasching, CE; Gerding, DN; Moody, JA; Peterson, LR | 2 |
| Grassi, C | 1 |
| Hernández, NI; Nevárez, M; Ramírez-Ronda, CH; Rodríguez, JR | 1 |
| Maslow, MJ; Rahal, JJ; Simberkoff, MS | 1 |
| Jeljaszewicz, J; Ko, HL; Pulverer, G; Roszkowski, K; Roszkowski, W | 1 |
| Andremont, AO; Tancrède, CH | 1 |
| Bryskier, A; Husson, MO; Izard, D; Leclerc, H; Vincent, P | 1 |
| Aguirre, X; Basauri, L; Prado, V; Zuleta, A | 1 |
| Anderson, H; Becerra, S; Godoy, J; Herrera, N; Jofre, M; Silva, J; Urdanivia, R | 1 |
| Goering, RV; Sanders, CC; Sanders, WE; Werner, V | 1 |
| Linda, H; Patzer, J | 1 |
| Mitrou, PS; Mondorf, AW; Scherberich, JE; Schoeppe, W; Stefanescu, T | 1 |
| Bernard, C; Gaya, H; Klastersky, J; Ryff, JC; Zinner, SH | 2 |
| Murray, PR | 1 |
| Aznar, J; Iglesias, MC; Martin, E; Nogales, MC; Perea, EJ | 1 |
| Chavanet, P; Cortet, P; Guy, H; Kazmierczak, A; Portier, H | 1 |
| Daschner, FD; Schneider, H; Steffens, A | 1 |
| Hayashi, A; Kitajima, S; Mochida, C; Nasu, M; Sawatari, K; Sotowa, K | 1 |
| Bauer, D; Spohr, M; Traub, WH | 1 |
| Watanakunakorn, C | 1 |
| Fleming, PJ; Hawkey, PM; Lewis, DA; Pitt, TL; Primavesi, RJ; Speller, DC | 1 |
| Angehrn, P | 1 |
| Balischewski, B; Kiessig, R; Köditz, H; Thal, W | 1 |
| Cobbs, CG; Elliott, AM; Karam, GH | 1 |
| Borrás, R; Brines, J; Escribano, A; Hernández, R; Lloret, J; Martínez Costa, C; Nogueira, JM | 1 |
| Meyer, RD; Pasiecznik, K | 1 |
| Jacquillat, C; Khayat, D; Maral, J | 1 |
| Accornero, L; Bacigalupo, A; Carella, AM; Congiu, AM; Costa, G; Occhini, D; Santini, G; Sbaffi, A; Sciutto, C; Van Lint, MT | 1 |
| Bayer, AS; Eisenstadt, R; Morrison, JO | 1 |
| Cavallo, JD; Chevalier, B; Meyran, M | 1 |
| Adjovi, DR; Cisse, MF; Samb, A; Sow, AI | 1 |
| Wang, F; Wang, YQ; Zhu, DM | 1 |
| Jog, A; Kulkarni, M; Lokeshwar, MR; Manglani, M; Patel, S; Rao, S | 1 |
| Anastassiadou, H; Dassiou, M; Samonis, G | 1 |
| Taher, AA | 1 |
| Schuler, D | 1 |
| López, MM; Martín, C; Merino, J; Navarro, V; Roig, PP; Sánchez, B; Zorraquino, A | 1 |
| Blesa Sánchez, E; Núñez Núñez, R; Vázquez Rueda, F | 1 |
| Caillon, J; Jacolot, A; Louchahi, K; Mimoz, O; Padoin, C; Petitjean, O; Samii, K; Tod, M | 1 |
| Bhutta, ZA | 1 |
| Blackshear, P; Branch, S; Chernoff, N; Hall, L | 1 |
| Hubbard, RW; Slocum, R | 1 |
| Christodoulou, C; Dellagrammaticas, HD; Kapetanakis, J; Kourakis, G; Megaloyanni, E; Papadimitriou, M | 1 |
| Domínguez, L; Garde, J; Herrero, IA; Moreno, MA; Porrero, MC; Teshager, T | 1 |
| Kushnareva, MV | 1 |
| Bal, AM; Ghadage, DP | 1 |
| Boukadida, J; Monastiri, K; Salem, N; Seket, B; Snoussi, N; Taher, NB | 1 |
| Hesse, Y; Lang, GK; Spraul, CW | 1 |
| Gonda, E; Kilár, F; Kocsis, B; Kustos, I; Kustos, T; Szabó, G | 1 |
| Cohen, JE; Rosenthal, G; Shoshan, Y; Spektor, S; Umansky, F; Valarezo, J; Valarezo, L | 1 |
| Harigae, H; Ishikawa, S; Kaku, M; Kanemitsu, K; Kunishima, H; Saga, T; Takemura, H | 1 |
| Chacko, AG; Chacko, G; Shankar, A | 1 |
| Avila-Agüero, ML; Huertas, E; Ulloa-Gutierrez, R | 1 |
| Akova, YA; Arslan, H; Aydin, P; Bozbeyoglu, S; Haberal, M; Yilmaz, G | 1 |
| Jakoniuk, P; Leszczyńska, K; Sacha, PT; Wieczorek, P; Zalewska, M | 1 |
| Biswal, M; Sharma, M; Taneja, N; Tarai, B | 1 |
| Chen, TA; Lai, KH; Lin, WJ; Lo, GH | 1 |
| Bukharin, OV; Chernikov, DA; Gritsenko, VA; Tret'iakov, AA | 1 |
| Abid, F; Ali Lachtar, M; Ayadi, A; Bedoui, A; Ben Homouda, H; Boussoffara, R; Braham, M; Mahjoub, B; Methlouthi, J; Sfar, MT | 1 |
| Cho, DT; Kang, HY; Kim, J; Kim, KY; Lee, JC; Lee, YC; Seol, SY | 1 |
| Béraud, G; Iba Ba, J; Legout, L; Mouton, Y; Senneville, E; Yazdanpanah, Y | 1 |
| Dalamaga, M; Daskalopoulou, K; Karmaniolas, K; Pantelaki, M; Papadavid, E | 1 |
| Dhanawade, SS; Kakade, GM; Shah, SD | 1 |
| Fajt, VR; Honnas, CM; Van House, AM | 1 |
| Ogunfowora, OB; Ogunlesi, TA; Olanrewaju, DM; Osinupebi, O | 1 |
| Armero, C; Gobernado, M; González, F; López-Quílez, A; Perpiñán, H; Sahuquillo-Arce, JM; Selva, M; Vanaclocha, H | 1 |
| Çetinkaya, M; Köksal, N; Özkan, H; Sarısözen, B; Yazıcı, Z | 1 |
| Kongthavonsakul, K; Oberdorfer, P; Washington, CH | 1 |
| Chantier, E; Gouache, E; Hubert, N; Rivière, MF | 1 |
| Bethou, A; Biswal, N; Mathai, B; Ramasamy, S | 1 |
| Guan, Z; Jiang, W; Lei, C; Li, Q; Liu, B; Pan, Y; Wang, H; Xu, C; Yang, C; Yang, Y; Zhang, A; Zhang, D | 1 |
| Cheng, G; Jiang, W; Kong, L; Lei, C; Liu, B; Shi, H; Wang, H; Wang, Y; Yang, X; Yang, Y; Zhang, A; Zhang, X | 1 |
| Abdelwahab, SI; Dafalla, OME; Homeida, HE; Taha, MME | 1 |
| Arrivé, L; Monnier-Cholley, L; Pacanowski, J; Roux, A | 1 |
| Ait Hamou, N; Amour, J; Bouglé, A; Dujardin, O; El-Helali, N; Lebreton, G; Lepère, V; Petijean, G; Salem, JE; Vidal, C | 1 |
| Al-Zaban, MI; AlHarbi, MA; Azim, NSA; Nofal, MY; Somily, AM | 1 |
| Caljon, B; Crombé, F; De Geyter, D; Demuyser, T; Janssen, T; Muyldermans, A; Piérard, D; Seyler, L; Vanstokstraeten, R; Wybo, I | 1 |
| Rishi, P; Sharma, A; Singh, R | 1 |
| Ölmez, S; Otlu, B; Sancak, B; Şener, B | 1 |
| Acman, M; Chiu, CH; Hamawandi, A; Lindsay, JA; Readman, JB; Sharland, M; Standing, JF | 1 |
5 review(s) available for amikacin and cefotaxime
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Respiratory infections: clinical evaluation.
Topics: Amikacin; Carbenicillin; Cefotaxime; Cystic Fibrosis; Drug Therapy, Combination; Enterobacteriaceae; Haemophilus influenzae; Humans; Piperacillin; Pseudomonas Infections; Respiratory Tract Infections; Streptococcus; Streptococcus pneumoniae; Tobramycin | 1985 |
[Retropharyngeal abscess. A report of 3 cases].
Topics: Amikacin; Anesthesia, General; Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Male; Retropharyngeal Abscess; Streptococcal Infections; Suction | 1996 |
Fulminant Listeria monocytogenes meningitis complicated with acute hydrocephalus in healthy children beyond the newborn period.
Topics: Acute Disease; Amikacin; Cefotaxime; Child; Child, Preschool; Combined Modality Therapy; Costa Rica; Dexamethasone; Drug Resistance; Drug Therapy, Combination; Emergencies; Fatal Outcome; Female; Humans; Hydrocephalus; Male; Meningitis, Listeria; Meropenem; Rifampin; Thienamycins; Tomography, X-Ray Computed; Vancomycin; Ventriculostomy | 2004 |
Neonatal osteofibrous dysplasia associated with pathological tibia fracture: a case report and review of the literature.
Topics: Amikacin; Anti-Bacterial Agents; Casts, Surgical; Cefotaxime; Clindamycin; Fibrous Dysplasia of Bone; Humans; Infant, Newborn; Infant, Newborn, Diseases; Male; Sepsis; Tibia; Tibial Fractures; Treatment Outcome | 2012 |
16 trial(s) available for amikacin and cefotaxime
| Article | Year |
|---|---|
Prophylactic antibiotherapy in urological surgery.
Topics: Amikacin; Cefotaxime; Clinical Protocols; Cross Infection; Humans; Portugal; Postoperative Complications; Premedication; Risk Factors; Urinary Catheterization; Urology | 1992 |
The pharmacokinetic of amikacin in critically ill adult and paediatric patients: comparison of once- versus twice-daily dosing regimens.
Topics: Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Cefotaxime; Ceftazidime; Child; Child, Preschool; Creatinine; Drug Administration Schedule; Female; Gram-Negative Aerobic Bacteria; Humans; Infant; Kidney; Male; Microbial Sensitivity Tests; Middle Aged | 1991 |
Clinical and bacteriological efficacy, and practical aspects of amikacin given once daily for severe infections.
Topics: Adult; Aged; Amikacin; Bacterial Infections; Cefotaxime; Ceftazidime; Cross Infection; Drug Administration Schedule; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Male; Middle Aged; Ofloxacin; Piperacillin; Prospective Studies | 1991 |
[Prospective, randomized, controlled study of imipenem-cilastatin versus cefotaxime-amikacin in the treatment of lower respiratory tract infection and septicemia at intensive care units].
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Cefotaxime; Cilastatin; Drug Therapy, Combination; Female; Humans; Imipenem; Intensive Care Units; Male; Middle Aged; Prospective Studies; Randomized Controlled Trials as Topic; Respiratory Tract Infections; Sepsis | 1990 |
Treatment of fever and neutropenia with antibiotics versus antibiotics plus intravenous gammaglobulin in childhood leukemia.
Topics: Agranulocytosis; Amikacin; Antineoplastic Agents; Cefotaxime; Child; Drug Therapy, Combination; Fever; Humans; Immunoglobulin G; Immunoglobulins, Intravenous; Infection Control; Leukemia, Myeloid, Acute; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1989 |
Therapeutic efficacy of the combination of aztreonam with cefotaxime in the treatment of severe nosocomial pneumonia. Comparative study against amikacin combined with cefotaxime.
Topics: Adult; Aged; Amikacin; Aztreonam; Cefotaxime; Clinical Trials as Topic; Cross Infection; Drug Therapy, Combination; Female; Humans; Intensive Care Units; Male; Middle Aged; Pneumonia; Random Allocation | 1989 |
[First-line treatment of febrile episodes in leukemia in adults. Randomized, multicenter study of ceftazidime in single antibiotic therapy versus a cefotaxime-amikacin combination].
Topics: Adult; Amikacin; Cefotaxime; Ceftazidime; Drug Evaluation; Drug Therapy, Combination; Fever; Humans; Leukemia; Multicenter Studies as Topic; Prospective Studies; Random Allocation | 1988 |
Piperacillin plus amikacin versus cefotaxime plus amikacin in neutropenic and feverish patients with malignant hemopathies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Agranulocytosis; Amikacin; Bacterial Infections; Cefotaxime; Drug Therapy, Combination; Female; Fever; Humans; Leukemia; Lymphoma; Male; Middle Aged; Neutropenia; Piperacillin; Prospective Studies | 1988 |
Cefotaxime (C) vs cefotaxime + amikacin (C + A) in the treatment of septicemia due to enterobacteria: a multicenter study.
Topics: Amikacin; Cefotaxime; Clinical Trials as Topic; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Sepsis | 1987 |
[Cefmenoxime or piperacillin plus amikacin. A prospective randomized comparison of empiric antibiotic therapy of febrile granulocytopenic cancer patients].
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Cefmenoxime; Cefotaxime; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neoplasms; Piperacillin; Prospective Studies; Random Allocation | 1987 |
Prospective randomized comparison of three antibiotic regimens for empirical therapy of suspected bacteremic infection in febrile granulocytopenic patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Azlocillin; Cefotaxime; Child; Clinical Trials as Topic; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Kanamycin; Male; Middle Aged; Penicillins; Prospective Studies; Random Allocation; Regression Analysis; Sepsis; Ticarcillin | 1986 |
In vitro and in vivo studies of three antibiotic combinations against gram-negative bacteria and Staphylococcus aureus.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Azlocillin; Cefotaxime; Enterobacteriaceae; Escherichia coli; Escherichia coli Infections; Humans; In Vitro Techniques; Klebsiella; Klebsiella Infections; Mice; Mice, Inbred BALB C; Penicillins; Pseudomonas aeruginosa; Serratia; Staphylococcus aureus | 1981 |
[Role of azlocillin in the treatment of immunocompromised patients. Results of the EORTC (European Organization for Research on the Treatment of Cancer) study)].
Topics: Agranulocytosis; Amikacin; Azlocillin; Bacterial Infections; Cefotaxime; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Neoplasms; Penicillins; Ticarcillin | 1984 |
Safety and efficacy of meropenem in hospitalised children: randomised comparison with cefotaxime, alone and combined with metronidazole or amikacin. Meropenem Paediatric Study Group.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Cefotaxime; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Drug Tolerance; Humans; Infant; Meropenem; Metronidazole; Thienamycins | 1995 |
Single daily amikacin versus cefotaxime in the short-course treatment of spontaneous bacterial peritonitis in cirrhotics.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cefotaxime; Humans; Liver Cirrhosis; Peritonitis; Retrospective Studies; Treatment Outcome | 2005 |
Comparison of two empiric antibiotic regimen in late onset neonatal sepsis--a randomized controlled trial.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cefotaxime; Cloxacillin; Drug Therapy, Combination; Female; Follow-Up Studies; Gentamicins; Hospitals, Teaching; Humans; India; Infant, Newborn; Infant, Premature; Infant, Very Low Birth Weight; Intensive Care Units, Neonatal; Length of Stay; Male; Outcome Assessment, Health Care; Sepsis; Single-Blind Method; Time Factors | 2014 |
154 other study(ies) available for amikacin and cefotaxime
| Article | Year |
|---|---|
Plasmid-mediated KPC-2 in a Klebsiella pneumoniae isolate from China.
Topics: beta-Lactam Resistance; beta-Lactamases; Carbapenems; China; Hospitals, University; Humans; Klebsiella pneumoniae; Molecular Sequence Data; Plasmids | 2007 |
Prevalence of plasmid-mediated quinolone resistance determinants QnrA, QnrB, and QnrS among clinical isolates of Enterobacter cloacae in a Taiwanese hospital.
Topics: Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Genes, Bacterial; Hospitals; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Prevalence; Quinolones; Taiwan | 2007 |
First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing beta-lactamase.
Topics: beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Hydrolysis; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 2007 |
Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Middle Aged; Portugal | 2007 |
Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Female; Humans; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Predictive Value of Tests; Proteus mirabilis; Risk Factors; Survival Analysis; Treatment Outcome | 2007 |
Spread in an Italian hospital of a clonal Acinetobacter baumannii strain producing the TEM-92 extended-spectrum beta-lactamase.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cross Infection; Humans; Italy; Microbial Sensitivity Tests | 2007 |
Enterobacteriaceae bloodstream infections: presence of integrons, risk factors, and outcome.
Topics: Bacteremia; Community-Acquired Infections; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae Infections; Gene Transfer, Horizontal; Humans; Infectious Disease Transmission, Professional-to-Patient; Integrons; Microbial Sensitivity Tests; Nucleic Acid Amplification Techniques; Polymerase Chain Reaction; Prospective Studies; Risk Factors; Sequence Analysis, DNA; Treatment Outcome | 2007 |
Extended-spectrum beta-lactamases of the CTX-M type now in Switzerland.
Topics: Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Hospitals, University; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Polymerase Chain Reaction; Prevalence; Switzerland | 2007 |
Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli.
Topics: Amino Acid Motifs; Amino Acid Sequence; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Conjugation, Genetic; Conserved Sequence; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Escherichia coli; Escherichia coli Proteins; Fluoroquinolones; Genes, rRNA; Methylation; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Norfloxacin; Plasmids; Sequence Analysis, DNA; Sequence Homology, Amino Acid | 2007 |
First occurrence of an Escherichia coli clinical isolate producing the VIM-1/VIM-2 hybrid metallo-beta-lactamase VIM-12.
Topics: Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Conjugation, Genetic; Escherichia coli; Escherichia coli Infections; Humans; Male; Microbial Sensitivity Tests; Plasmids; Recombination, Genetic | 2007 |
Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate.
Topics: Bacterial Proteins; Base Sequence; beta-Lactamases; Carrier Proteins; Cloning, Molecular; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Genes, MDR; Genetic Vectors; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Porins | 2007 |
An OXA-66/OXA-51-like carbapenemase and possibly an efflux pump are associated with resistance to imipenem in Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacterial Proteins; Base Sequence; beta-Lactamases; Drug Resistance, Bacterial; Electrophoresis, Gel, Two-Dimensional; Electrophoresis, Polyacrylamide Gel; Gene Expression Regulation, Bacterial; Humans; Imipenem; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sequence Homology, Nucleic Acid | 2007 |
Prevalence and expression of the plasmid-mediated quinolone resistance determinant qnrA1.
Topics: Anti-Infective Agents; Base Sequence; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae; Gene Expression Regulation, Bacterial; Genes, Bacterial; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Polymerase Chain Reaction; Promoter Regions, Genetic; Quinolones; Reverse Transcriptase Polymerase Chain Reaction; Sequence Analysis, DNA; Sequence Homology, Nucleic Acid | 2007 |
Escherichia coli isolate coproducing 16S rRNA Methylase and CTX-M-type extended-spectrum beta-lactamase isolated from an outpatient in the United States.
Topics: Ambulatory Care; Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Humans; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; RNA, Ribosomal, 16S; Sequence Analysis, DNA; United States | 2008 |
Plasmid-mediated qepA gene among Escherichia coli clinical isolates from Japan.
Topics: Anti-Bacterial Agents; Conjugation, Genetic; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Fluoroquinolones; Hospitals; Humans; Japan; Microbial Sensitivity Tests; Plasmids; Prevalence | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Molecular characterization and epidemiology of extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates causing health care-associated infection in Thailand, where the CTX-M family is endemic.
Topics: Adult; Bacterial Proteins; beta-Lactamases; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Endemic Diseases; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Polymerase Chain Reaction; Sequence Analysis, DNA; Thailand | 2008 |
Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Models, Genetic; Turkey | 2008 |
Characterization of the new metallo-beta-lactamase VIM-13 and its integron-borne gene from a Pseudomonas aeruginosa clinical isolate in Spain.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Cloning, Molecular; DNA Primers; DNA, Bacterial; Genes, Bacterial; Genetic Variation; Humans; Imipenem; Integrons; Kinetics; Meropenem; Molecular Sequence Data; Phylogeny; Pseudomonas aeruginosa; Pseudomonas Infections; Recombinant Proteins; Sequence Homology, Amino Acid; Spain; Thienamycins | 2008 |
Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France.
Topics: Aged; Base Sequence; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Fluoroquinolones; France; Genes, Bacterial; Humans; Models, Genetic; Molecular Sequence Data; Plasmids | 2008 |
High prevalence of plasmid-mediated quinolone resistance genes qnr and aac(6')-Ib-cr in clinical isolates of Enterobacteriaceae from nine teaching hospitals in China.
Topics: Acetyltransferases; Anti-Bacterial Agents; Bacterial Proteins; China; Conjugation, Genetic; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals, Teaching; Humans; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction; Prevalence; Quinolones | 2008 |
Plasmid-mediated 16S rRNA methylases among extended-spectrum beta-lactamase-producing Enterobacteriaceae isolates.
Topics: Anti-Bacterial Agents; beta-Lactamases; Conjugation, Genetic; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Escherichia coli; Humans; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Sequence Analysis, DNA; Transformation, Bacterial | 2008 |
Widespread dissemination of aminoglycoside resistance genes armA and rmtB in Klebsiella pneumoniae isolates in Taiwan producing CTX-M-type extended-spectrum beta-lactamases.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Blotting, Southern; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Klebsiella pneumoniae; Taiwan | 2009 |
High prevalence of plasmid-mediated quinolone resistance determinants qnr, aac(6')-Ib-cr, and qepA among ceftiofur-resistant Enterobacteriaceae isolates from companion and food-producing animals.
Topics: Acetyltransferases; Adolescent; Adult; Aged; Animals; Animals, Domestic; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cambodia; Cephalosporins; China; Conjugation, Genetic; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli Proteins; Female; Humans; Male; Mali; Microbial Sensitivity Tests; Middle Aged; Nasal Cavity; Plasmids; Quinolones; Young Adult | 2009 |
Nationwide survey of CTX-M-type extended-spectrum beta-lactamases among Klebsiella pneumoniae isolates in Slovenian hospitals.
Topics: Anti-Bacterial Agents; beta-Lactamases; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Hospitals; Klebsiella pneumoniae; Microbial Sensitivity Tests; Slovenia | 2009 |
Detection of the pandemic O25-ST131 human virulent Escherichia coli CTX-M-15-producing clone harboring the qnrB2 and aac(6')-Ib-cr genes in a dog.
Topics: Animals; Anti-Bacterial Agents; Dogs; Drug Resistance, Bacterial; Escherichia coli; Genes, Bacterial; Humans; Plasmids; Virulence | 2009 |
Carbapenem resistance among Pseudomonas aeruginosa strains from India: evidence for nationwide endemicity of multiple metallo-beta-lactamase clones (VIM-2, -5, -6, and -11 and the newly characterized VIM-18).
Topics: Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Humans; India; Microbial Sensitivity Tests; Molecular Sequence Data; Prevalence; Pseudomonas aeruginosa; Ribotyping | 2009 |
blaCTX-M genes in escherichia coli strains from Croatian Hospitals are located in new (blaCTX-M-3a) and widely spread (blaCTX-M-3a and blaCTX-M-15) genetic structures.
Topics: Base Sequence; beta-Lactamases; DNA Transposable Elements; Escherichia coli; Molecular Sequence Data; Plasmids; Polymerase Chain Reaction | 2009 |
First organisms with acquired metallo-beta-lactamases (IMP-13, IMP-22, and VIM-2) reported in Austria.
Topics: Austria; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Pseudomonas aeruginosa; Pseudomonas Infections; Sequence Analysis, DNA | 2009 |
Further identification of CTX-M-2 extended-spectrum beta-lactamase in Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Brazil; Ceftriaxone; Clindamycin; Drug Resistance, Multiple, Bacterial; Fatal Outcome; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections | 2009 |
New plasmid-mediated quinolone resistance gene, qnrC, found in a clinical isolate of Proteus mirabilis.
Topics: Amino Acid Sequence; Anti-Infective Agents; Bacterial Proteins; Base Sequence; Conjugation, Genetic; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Polymerase Chain Reaction; Proteus Infections; Proteus mirabilis; Quinolones; Sequence Analysis, DNA | 2009 |
Emergence of high levels of extended-spectrum-beta-lactamase-producing gram-negative bacilli in the Asia-Pacific region: data from the Study for Monitoring Antimicrobial Resistance Trends (SMART) program, 2007.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; China; Drug Resistance, Bacterial; Ertapenem; Escherichia coli; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Imipenem; India; Klebsiella; Quinolones; Thailand | 2009 |
Emergence of Klebsiella pneumoniae ST258 with KPC-2 in Poland.
Topics: Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Multiple, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Molecular Sequence Data; Poland | 2009 |
Complete nucleotide sequences of plasmids pEK204, pEK499, and pEK516, encoding CTX-M enzymes in three major Escherichia coli lineages from the United Kingdom, all belonging to the international O25:H4-ST131 clone.
Topics: beta-Lactamases; Computational Biology; Escherichia coli; Models, Genetic; Molecular Sequence Data; Open Reading Frames; Plasmids; United Kingdom | 2009 |
Emergence of an Enterobacter hormaechei strain with reduced susceptibility to tigecycline under tigecycline therapy.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterobacter; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Tigecycline | 2009 |
Phenotypic and genotypic characterization of Enterobacteriaceae with decreased susceptibility to carbapenems: results from large hospital-based surveillance studies in China.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactamases; Carbapenems; China; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae; Enterobacteriaceae Infections; Genotype; Integrons; Microbial Sensitivity Tests; Phenotype; Population Surveillance; Porins; Reverse Transcriptase Polymerase Chain Reaction | 2010 |
First isolation of the blaOXA-23 carbapenemase gene from an environmental Acinetobacter baumannii isolate.
Topics: Acinetobacter baumannii; beta-Lactamases; DNA, Bacterial; Escherichia coli; France; Genes, Bacterial; Water Microbiology | 2010 |
Screening and quantification of the expression of antibiotic resistance genes in Acinetobacter baumannii with a microarray.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; DNA, Bacterial; DNA, Complementary; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Genes, MDR; Metals, Heavy; Microbial Sensitivity Tests; Mutation; Oligonucleotide Array Sequence Analysis; Reproducibility of Results; Reverse Transcriptase Polymerase Chain Reaction; RNA, Bacterial | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Acinetobacter baumannii increases tolerance to antibiotics in response to monovalent cations.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Proteins; Cations, Monovalent; Culture Media; Drug Resistance, Bacterial; Gene Expression Profiling; Gene Expression Regulation, Bacterial; Humans; Microbial Sensitivity Tests; Oligonucleotide Array Sequence Analysis; Proteomics; Sodium Chloride; Virulence Factors | 2010 |
Detection of KPC in Acinetobacter spp. in Puerto Rico.
Topics: Acinetobacter; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; beta-Lactam Resistance; beta-Lactamases; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Population Surveillance; Puerto Rico | 2010 |
Efflux pumps, OprD porin, AmpC beta-lactamase, and multiresistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
Topics: Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactamases; Cystic Fibrosis; Drug Resistance, Bacterial; Drug Resistance, Multiple; Electrophoresis, Gel, Pulsed-Field; Humans; Membrane Transport Proteins; Mutation; Porins; Pseudomonas aeruginosa; Pseudomonas Infections; Reverse Transcriptase Polymerase Chain Reaction; Up-Regulation | 2010 |
Incidence and antimicrobial susceptibility of Escherichia coli and Klebsiella pneumoniae with extended-spectrum beta-lactamases in community- and hospital-associated intra-abdominal infections in Europe: results of the 2008 Study for Monitoring Antimicrob
Topics: Abdomen; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae | 2010 |
Susceptibility of gram-negative pathogens isolated from patients with complicated intra-abdominal infections in the United States, 2007-2008: results of the Study for Monitoring Antimicrobial Resistance Trends (SMART).
Topics: Abdomen; Amikacin; beta-Lactams; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Ertapenem; Escherichia coli; Gram-Negative Bacteria; Humans; Imipenem; Microbial Sensitivity Tests | 2010 |
Acquisition of a transposon encoding extended-spectrum beta-lactamase SHV-12 by Pseudomonas aeruginosa isolates during the clinical course of a burn patient.
Topics: Adult; beta-Lactamases; Burns; DNA Transposable Elements; Female; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Pseudomonas aeruginosa | 2010 |
Antimicrobial resistance testing of verocytotoxin-producing Escherichia coli and first description of TEM-52 extended-spectrum β-lactamase in serogroup O26.
Topics: Adhesins, Bacterial; Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Proteins; Humans; Plasmids; Shiga Toxins | 2010 |
In vivo selection of a missense mutation in adeR and conversion of the novel blaOXA-164 gene into blaOXA-58 in carbapenem-resistant Acinetobacter baumannii isolates from a hospitalized patient.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacterial Proteins; Carbapenems; Drug Resistance, Bacterial; Fatal Outcome; Humans; Male; Middle Aged; Molecular Sequence Data; Mutation, Missense; Reverse Transcriptase Polymerase Chain Reaction | 2010 |
Bile Acid Oligomers and Their Combination with Antibiotics To Combat Bacterial Infections.
Topics: Anti-Bacterial Agents; Bile Acids and Salts; Drug Interactions; Drug Resistance, Bacterial; Escherichia coli; HEK293 Cells; Humans; Staphylococcus aureus | 2018 |
Microwave-assisted solid-phase synthesis of antisense acpP peptide nucleic acid-peptide conjugates active against colistin- and tigecycline-resistant E. coli and K. pneumoniae.
Topics: Anti-Bacterial Agents; Colistin; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Escherichia coli; Klebsiella pneumoniae; Microbial Sensitivity Tests; Microwaves; Molecular Structure; Peptide Nucleic Acids; Peptides; Solid-Phase Synthesis Techniques; Structure-Activity Relationship; Tigecycline | 2019 |
[Effectiveness of cefotaxime in experimental plague infection].
Topics: Amikacin; Animals; Cefazolin; Cefmetazole; Cefotaxime; Cephalothin; Drug Therapy, Combination; Mice; Plague | 1992 |
[Effectiveness of phosphomycin and its combinations with amikacin and cefotaxime in experimental plague infection].
Topics: Amikacin; Animals; Cefotaxime; Drug Synergism; Drug Therapy, Combination; Fosfomycin; Injections, Intramuscular; Mice; Plague | 1992 |
Multiresistant Klebsiella pneumoniae in a neonatal nursery: the importance of maintenance of infection control policies and procedures in the prevention of outbreaks.
Topics: Amikacin; Carrier State; Cefotaxime; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Hospitals, Teaching; Humans; Infant; Infant, Newborn; Infection Control; Klebsiella Infections; Klebsiella pneumoniae; Methicillin Resistance; Microbial Sensitivity Tests; Nurseries, Hospital; South Africa | 1992 |
Beta-lactam enhancement of aminoglycoside activity under conditions of reduced pH and oxygen tension that may exist in infected tissues.
Topics: Abscess; Aerobiosis; Amikacin; Anaerobiosis; Animals; Anti-Bacterial Agents; Bacteroides fragilis; Cefotaxime; Drug Synergism; Enterobacteriaceae; Escherichia coli; Humans; Hydrogen-Ion Concentration; Mice; Oxygen; Pseudomonas aeruginosa; Ticarcillin; Tobramycin | 1992 |
Successful treatment of infected thoracoabdominal aortic graft by percutaneous catheter drainage.
Topics: Aged; Amikacin; Aorta, Abdominal; Aorta, Thoracic; Blood Vessel Prosthesis; Catheterization; Cefotaxime; Drainage; Female; Humans; Klebsiella Infections; Polyethylene Terephthalates | 1991 |
Differences in release of tumor necrosis factor from THP-1 cells stimulated by filtrates of antibiotic-killed Escherichia coli.
Topics: Amikacin; Anti-Bacterial Agents; Aztreonam; Cefotaxime; Ceftazidime; Ciprofloxacin; Dose-Response Relationship, Drug; Escherichia coli; Humans; Imipenem; Leukemia, Monocytic, Acute; Leukocytes, Mononuclear; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1991 |
[Salmonella typhimurium infections in the area of Bursa].
Topics: Adult; Amikacin; Anti-Bacterial Agents; Cefotaxime; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Salmonella Infections; Salmonella typhimurium; Sepsis; Turkey | 1990 |
Hospital-acquired neonatal bacterial meningitis: the impacts of cefotaxime usage on mortality and of amikacin usage on incidence.
Topics: Amikacin; Cefotaxime; Cross Infection; Humans; Infant, Newborn; Meningitis; South Africa | 1989 |
[An epidemiologic study of the antibiotic susceptibility of bacteria isolated from patients with urinary tract infections].
Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Bacteria; Cefotaxime; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Ofloxacin; Prevalence; Turkey; Urinary Tract Infections | 1989 |
[Antibiotics used for paratyphi B infections resistant to classical treatment and the results of their use].
Topics: Amikacin; Ampicillin Resistance; Cefotaxime; Cephalosporins; Child, Preschool; Chloramphenicol; Drug Resistance, Microbial; Humans; Infant; Paratyphoid Fever; Salmonella; Salmonella paratyphi B; Trimethoprim, Sulfamethoxazole Drug Combination | 1989 |
[Combined chemotherapy of experimental infection in neutropenia].
Topics: Agranulocytosis; Amikacin; Animals; Azlocillin; Cefotaxime; Drug Synergism; Drug Therapy, Combination; Escherichia coli Infections; Immune Tolerance; Klebsiella Infections; Mice; Neutropenia; Opportunistic Infections; Pseudomonas Infections | 1989 |
Canaliculitis caused by Mycobacterium chelonae after lacrimal intubation with silicone tubes.
Topics: Amikacin; Cefotaxime; Conjunctivitis, Bacterial; Humans; Intubation; Lacrimal Duct Obstruction; Male; Middle Aged; Mycobacterium Infections; Reoperation; Silicone Elastomers | 1989 |
Enhanced in-vitro bactericidal activity of amikacin combined with latamoxef, cefotaxime and aztreonam against multi-resistant Enterobacter cloacae.
Topics: Amikacin; Aztreonam; beta-Lactamases; Cefotaxime; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae; Microbial Sensitivity Tests; Moxalactam; Time Factors | 1989 |
Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae.
Topics: Amikacin; beta-Lactamases; Cefotaxime; Cephalosporins; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Enterobacteriaceae; Escherichia coli; Humans; Klebsiella Infections; Klebsiella pneumoniae; Paris; Recurrence; Urinary Tract Infections | 1987 |
Bactericidal activity of ciprofloxacin against amikacin- and cefotaxime-resistant gram-negative bacilli and methicillin-resistant staphylococci.
Topics: Amikacin; Cefotaxime; Ciprofloxacin; Cross Infection; Gram-Negative Bacteria; Humans; Kanamycin; Methicillin; Penicillin Resistance; Quinolines; Staphylococcus | 1986 |
[Evaluation of the bactericidal curves of beta-lactam and aminoglycoside combinations at the concentrations obtained in the cerebrospinal fluid in Haemophilus influenzae meningitis].
Topics: Amikacin; Amoxicillin; Anti-Bacterial Agents; Cefotaxime; Child; Dose-Response Relationship, Drug; Drug Therapy, Combination; Haemophilus influenzae; Humans; Meningitis, Haemophilus; Time Factors | 1987 |
Myonecrosis of the abdominal wall, complicating radical hysterectomy.
Topics: Abdominal Muscles; Amikacin; Bacillus; Cefotaxime; Clindamycin; Drug Therapy, Combination; Escherichia coli; Female; Humans; Hysterectomy; Leiomyoma; Metronidazole; Middle Aged; Necrosis; Penicillin G; Peptostreptococcus; Surgical Wound Infection; Uterine Neoplasms | 1987 |
Ciprofloxacin, azlocillin, ceftizoxime and amikacin alone and in combination against gram-negative bacilli in an infected chamber model.
Topics: Amikacin; Animals; Azlocillin; Cefotaxime; Ceftizoxime; Ciprofloxacin; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Gram-Negative Bacteria; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Rabbits | 1986 |
Stability of ampicillin, piperacillin, cefotaxime, netilmicin and amikacin in an L-amino acid solution prepared for total parenteral nutrition of newborn infants.
Topics: Amikacin; Amino Acids; Ampicillin; Anti-Bacterial Agents; Cefotaxime; Drug Interactions; Drug Stability; Electrolytes; Glucose; Humans; Infant, Newborn; Netilmicin; Parenteral Nutrition Solutions; Parenteral Nutrition, Total; Piperacillin; Solutions; Temperature; Time Factors | 1988 |
Interaction of aminoglycosides and cephalosporins against Pseudomonas aeruginosa. Correlation between interaction index and killing curve.
Topics: Amikacin; Anti-Bacterial Agents; Cefotaxime; Ceftazidime; Cephalosporins; Culture Media; Drug Resistance, Microbial; Drug Synergism; Gentamicins; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Sisomicin | 1988 |
[Pneumonia caused by Mycobacterium chelonei. Apropos of a case].
Topics: Aged; Aged, 80 and over; Amikacin; Cefotaxime; Female; Humans; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Pneumonia | 1988 |
Bacteremia in neutropenic patients at a major teaching hospital--1981 to 1987.
Topics: Agranulocytosis; Amikacin; Australia; Cefotaxime; Drug Therapy, Combination; Gentamicins; Hospitals, Teaching; Humans; Neutropenia; Piperacillin; Sepsis; Ticarcillin | 1988 |
[Microorganisms isolated in 54 patients receiving bone marrow transplants and evaluation of their sensitivity to antimicrobial agents].
Topics: Amikacin; Anti-Bacterial Agents; Azlocillin; Bacterial Infections; Bone Marrow Transplantation; Cefotaxime; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Penicillin Resistance | 1987 |
Activity of cefotaxime and amikacin against 14,272 gram-negative bacteria from clinical samples in the period 1980 to 1985.
Topics: Amikacin; Cefotaxime; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Enterobacteriaceae; Time Factors | 1988 |
Comparison of two versus three daily infusions of cefotaxime plus amikacin in granulocytopenic children.
Topics: Agranulocytosis; Amikacin; Bacterial Infections; Cefotaxime; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans | 1988 |
Antimicrobial activity of cefotiam combinations against Enterobacteriaceae moderately susceptible or resistant to this new cephalosporin.
Topics: Amikacin; Cefotaxime; Cefotiam; Drug Combinations; Drug Resistance, Microbial; Drug Synergism; Enterobacteriaceae; Gentamicins; Microbial Sensitivity Tests; Netilmicin; Tobramycin | 1986 |
Treatment of ciprofloxacin- and ceftizoxime-induced resistant gram-negative bacilli.
Topics: Amikacin; Animals; Azlocillin; Bacterial Infections; Cefotaxime; Ceftizoxime; Ciprofloxacin; Drug Evaluation, Preclinical; Female; Gram-Negative Bacteria; Penicillin Resistance; Rabbits | 1987 |
In vitro activity of pefloxacin.
Topics: Amikacin; Anti-Infective Agents; Cefotaxime; Ceftazidime; Mezlocillin; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Penicillin Resistance | 1986 |
[Malignant otitis externa. Presentation of a case].
Topics: Amikacin; Cefotaxime; Humans; Infant; Male; Otitis Externa; Pseudomonas Infections | 1987 |
Strategies in aminoglycoside use and impact upon resistance.
Topics: Acinetobacter; Amikacin; Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Drug Interactions; Drug Therapy, Combination; Enterobacteriaceae; Gentamicins; Humans; Penicillin Resistance; Pseudomonas; R Factors; Risk; Staphylococcus | 1986 |
Management of sepsis in the elderly.
Topics: Aged; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Cefotaxime; Cross Infection; Drug Therapy, Combination; Female; Humans; Male; Pneumonia; Risk; Shock, Septic; Urinary Tract Infections | 1986 |
Mezlocillin, ceftizoxime, and amikacin alone and in combination against six Enterobacteriaceae in a neutropenic site in rabbits.
Topics: Agranulocytosis; Amikacin; Animals; Cefotaxime; Ceftizoxime; Drug Combinations; Enterobacteriaceae; Female; Hydrogen-Ion Concentration; Kanamycin; Mezlocillin; Microbial Sensitivity Tests; Neutropenia; Rabbits | 1985 |
[In vitro study of the synergistic effect of cefotiam- aminoglycoside combinations on strains of low susceptibility to this cephalosporin].
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Cefotaxime; Cefotiam; Drug Resistance, Microbial; Drug Synergism; Enterobacteriaceae; Gentamicins; Microbial Sensitivity Tests; Netilmicin; Tobramycin | 1985 |
Interaction of third generation cephalosporins combined with amikacin against Pseudomonas aeruginosa.
Topics: Amikacin; Cefoperazone; Cefotaxime; Ceftizoxime; Cephalosporins; Drug Synergism; Kanamycin; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa | 1985 |
Clinical efficacy of a synergistic combination of cefotaxime and amikacin against multiresistant Pseudomonas and Serratia infections.
Topics: Aged; Amikacin; Aminoglycosides; Cefotaxime; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae Infections; Humans; Kanamycin; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Serratia marcescens | 1985 |
Antibiotics and immunomodulation: effects of cefotaxime, amikacin, mezlocillin, piperacillin and clindamycin.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Antibody Formation; Cefotaxime; Clindamycin; Hypersensitivity, Delayed; Immune System; Immunosuppressive Agents; In Vitro Techniques; Lymphocyte Activation; Male; Mezlocillin; Mice; Mice, Inbred BALB C; Piperacillin | 1985 |
Forecast of antibiotic susceptibility of translocating strains of enterobacteria and pseudomonas in leukemic neutropenic patients.
Topics: Agranulocytosis; Amikacin; Ampicillin; Anti-Bacterial Agents; Cefotaxime; Enterobacteriaceae; Feces; Gentamicins; Humans; Leukemia; Microbial Sensitivity Tests; Neutropenia; Pseudomonas | 1985 |
Combination effect of cefmenoxime with four aminoglycosides on Enterobacteriaceae susceptible and moderately susceptible to this new cephalosporin.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Cefmenoxime; Cefotaxime; Drug Resistance, Microbial; Drug Synergism; Enterobacteriaceae; Enterobacteriaceae Infections; Gentamicins; Humans; Netilmicin; Species Specificity; Tobramycin | 1984 |
[Ceftriaxone by systemic route combined with amikacin by intraventricular route in the treatment of ventriculitis in children with hydrocephalus].
Topics: Amikacin; Cefotaxime; Ceftriaxone; Cerebral Ventricles; Cerebrospinal Fluid Shunts; Drug Therapy, Combination; Encephalitis; Humans; Hydrocephalus; Injections, Intraventricular; Kanamycin | 1984 |
[In vitro activity of cefotaxime (HR 756) compared with cephalexin, gentamycin and amikacin against Gram-negative bacteria and urinary infections].
Topics: Amikacin; Cefotaxime; Cephalexin; Enterobacteriaceae; Gentamicins; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Urinary Tract Infections | 1983 |
Selection of multiple antibiotic resistance by quinolones, beta-lactams, and aminoglycosides with special reference to cross-resistance between unrelated drug classes.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Cefotaxime; Ciprofloxacin; Enterobacter; Enterobacteriaceae; Humans; Klebsiella pneumoniae; Mezlocillin; Mutation; Nalidixic Acid; Norfloxacin; Penicillin Resistance; Quinolines | 1984 |
[Combined effect of cefotaxime and aminoglycoside antibiotics on Pseudomonas strains and group D streptococci].
Topics: Amikacin; Cefotaxime; Drug Synergism; Enterococcus faecalis; Gentamicins; In Vitro Techniques; Kanamycin; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Sisomicin | 1984 |
Elimination of brush border membrane protein in urine caused by toxic alterations of the tubular cell.
Topics: Adolescent; Adult; Amikacin; Aminopeptidases; Anti-Bacterial Agents; CD13 Antigens; Cefotaxime; Cell Membrane; Cephalosporins; Cisplatin; Female; Humans; Kidney Tubules, Proximal; Kinetics; Male; Membrane Proteins; Microvilli; Middle Aged; Netilmicin; Sulfonylurea Compounds | 1981 |
Cefotaxime and amikacin: results of in vitro and in vivo studies against Gram-negative bacteria and Staphylococcus aureus. EORTC International Antimicrobial Therapy Project Group.
Topics: Amikacin; Animals; Bacteria; Bacterial Infections; Cefotaxime; Cephalosporins; Drug Synergism; Humans; Kanamycin; Mice; Staphylococcus aureus | 1980 |
Activity of cefotaxime-aminoglycoside combinations against aminoglycoside-resistant Pseudomonas.
Topics: Amikacin; Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Drug Resistance, Microbial; Drug Synergism; Gentamicins; Humans; Kanamycin; Pseudomonas aeruginosa; Tobramycin | 1980 |
Synergy between cefotaxime, cefsulodin, azlocillin, mezlocillin and aminoglycosides against carbenicillin resistant or sensitive Pseudomonas aeruginosa.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Carbenicillin; Cefotaxime; Cefsulodin; Cephalosporins; Dibekacin; Drug Synergism; Gentamicins; Mezlocillin; Penicillin Resistance; Penicillins; Pseudomonas aeruginosa; Sisomicin; Tobramycin | 1980 |
[Combined cefotaxime-amikacin treatment of infectious episodes in acute leukaemia patients with therapeutically-induced bone marrow aplasia (author's transl)].
Topics: Acute Disease; Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Cefotaxime; Cephalosporins; Drug Therapy, Combination; Humans; Kanamycin; Leukemia; Middle Aged | 1981 |
In-vitro efficacy of cefotiam in combination with four aminoglycosides on staphylococci and Gram-negative bacteria.
Topics: Amikacin; Aminoglycosides; Cefotaxime; Cefotiam; Drug Interactions; Enterobacteriaceae; Escherichia coli; Gentamicins; Klebsiella pneumoniae; Netilmicin; Proteus; Staphylococcus; Tobramycin | 1981 |
[Antibacterial activity of cefotaxime against main bacteria isolated from clinical samples (author's transl)].
Topics: Amikacin; Ampicillin; Bacteria; Cefazolin; Cefmetazole; Cefotaxime; Cephamycins; Gentamicins; Humans; Penicillin Resistance | 1981 |
Plasmid-independent resistance of 'gray' colony variants of a strain of Serratia marcescens resistant to amikacin, cefotaxime and lamoxactam.
Topics: Amikacin; Anti-Bacterial Agents; Cefotaxime; Cephamycins; Culture Media; DNA, Bacterial; Drug Resistance, Microbial; Moxalactam; Plasmids; Serratia marcescens | 1983 |
In vitro activity of ceftriaxone alone and in combination with gentamicin, tobramycin, and amikacin against Pseudomonas aeruginosa.
Topics: Amikacin; Cefotaxime; Ceftriaxone; Drug Synergism; Gentamicins; Kanamycin; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Tobramycin | 1983 |
Infection with netilmicin resistant Serratia marcescens in a special care baby unit.
Topics: Acetyltransferases; Amikacin; Cefotaxime; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Enterobacteriaceae Infections; Gentamicins; Humans; Infant, Newborn; Netilmicin; Nurseries, Hospital; Serratia marcescens; Tobramycin | 1983 |
In vitro and in vivo synergy between ceftriaxone and aminoglycosides against Pseudomonas aeruginosa.
Topics: Amikacin; Animals; Cefotaxime; Ceftriaxone; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Gentamicins; Kanamycin; Leukopenia; Mice; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 1983 |
[Antibacterial activities of amicacin, azlocillin and cefotaxim in bronchial secretion and serum of children].
Topics: Amikacin; Anti-Infective Agents; Azlocillin; Bronchi; Cefotaxime; Child; Humans; Kanamycin; Penicillins | 1983 |
Interaction of cefotaxime and aminoglycosides against enterococci in vitro.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Cefotaxime; Drug Interactions; Enterococcus faecalis; Gentamicins; Microbial Sensitivity Tests; Streptococcus; Time Factors; Tobramycin | 1983 |
[Treatment of type-b H. influenzae meningitis resistant to ampicillin and chloramphenicol].
Topics: Amikacin; Ampicillin; Cefotaxime; Cefoxitin; Chloramphenicol; Female; Gentamicins; Humans; Infant; Infant, Newborn; Male; Meningitis, Haemophilus; Penicillin Resistance; Rifampin | 1983 |
In vitro activity of newer beta-lactam agents in combination with amikacin against Pseudomonas aeruginosa, Klebsiella pneumoniae, and Serratia marcescens.
Topics: Amikacin; Anti-Bacterial Agents; Cefoperazone; Cefotaxime; Ceftazidime; Ceftizoxime; Cephalosporins; Drug Synergism; Imipenem; Kanamycin; Klebsiella pneumoniae; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa; Serratia marcescens; Thienamycins | 1983 |
Cefoperazone versus cefotaxime, plus amikacin or sisomicin, in fever and infection in hematologic granulocytopenic patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Anemia, Aplastic; Cefoperazone; Cefotaxime; Drug Therapy, Combination; Female; Fever; Humans; Immunosuppression Therapy; Infections; Kanamycin; Leukemia; Male; Middle Aged; Random Allocation; Sisomicin | 1984 |
Comparison of azlocillin, ceftizoxime, cefoxitin, and amikacin alone and in combination against Pseudomonas aeruginosa in a neutropenic-site rabbit model.
Topics: Agranulocytosis; Amikacin; Animals; Anti-Bacterial Agents; Azlocillin; Cefotaxime; Cefoxitin; Ceftizoxime; Disease Models, Animal; Drug Combinations; Female; Hydrogen-Ion Concentration; Kanamycin; Microbial Sensitivity Tests; Neutropenia; Penicillins; Protein Binding; Pseudomonas Infections; Rabbits | 1984 |
Enhanced in vitro bactericidal activity of amikacin or gentamicin combined with three new extended-spectrum cephalosporins against cephalothin-resistant members of the family Enterobacteriaceae.
Topics: Amikacin; Cefotaxime; Ceftazidime; Ceftizoxime; Ceftriaxone; Cephalosporins; Cephalothin; Drug Resistance, Microbial; Drug Synergism; Enterobacteriaceae; Gentamicins; Kanamycin; Time Factors | 1984 |
[Bactericidal activity of 6 antibiotics and 3 combinations against 6 strains of Salmonella isolated from blood].
Topics: Amikacin; Anti-Bacterial Agents; Cefoperazone; Cefotaxime; Ceftriaxone; Chloramphenicol; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; In Vitro Techniques; Salmonella | 1995 |
[Bacteriological study of purulent otitis media in children in CHU in the tropical zone].
Topics: Adolescent; Amikacin; Cefotaxime; Child; Child, Preschool; Female; Hospitals, University; Humans; Infant; Infant, Newborn; Klebsiella; Male; Otitis Media, Suppurative; Proteus; Pseudomonas aeruginosa; Retrospective Studies; Senegal; Staphylococcus aureus; Tropical Climate | 1995 |
[Bacterial resistance in clinical isolates of Klebsiella pneumoniae].
Topics: Acetyltransferases; Amikacin; Ampicillin Resistance; Cefotaxime; Cross Infection; Drug Resistance, Microbial; Humans; Klebsiella pneumoniae | 1995 |
Klebsiella pneumoniae osteomyelitis in sickle cell anemia.
Topics: Amikacin; Anemia, Sickle Cell; Cefotaxime; Child; Diagnosis, Differential; Humans; Injections, Intravenous; Klebsiella pneumoniae; Male; Osteomyelitis | 1994 |
Antibiotics affecting gastrointestinal colonization of mice by yeasts.
Topics: Amikacin; Amoxicillin; Animals; Anti-Bacterial Agents; Candida albicans; Candidiasis; Cefotaxime; Digestive System; Disease Models, Animal; Feces; Gastrointestinal Diseases; Male; Mice; Mice, Inbred ICR; Pefloxacin | 1994 |
Osteomyelitis of the mandible in Tehran, Iran. Analysis of 88 cases.
Topics: Adolescent; Adult; Aged; Amikacin; Cefotaxime; Child; Child, Preschool; Clindamycin; Female; Humans; Incidence; Infant; Infant, Newborn; Iran; Male; Mandibular Diseases; Mandibular Injuries; Middle Aged; Mouth Neoplasms; Osteomyelitis; Periapical Abscess; Radiotherapy | 1993 |
[Bacteremia caused by Capnocytophaga sp: presentation of 2 cases, one with endocarditis. Review of the literature].
Topics: Adult; Aged; Amikacin; Anti-Bacterial Agents; Bacteremia; Capnocytophaga; Cefotaxime; Ceftazidime; Cephalosporins; Endocarditis, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Male | 1996 |
Cefepime and amikacin synergy against a cefotaxime-susceptible strain of Enterobacter cloacae in vitro and in vivo.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Cefepime; Cefotaxime; Cephalosporins; Drug Resistance, Microbial; Drug Synergism; Enterobacter cloacae; Enterobacteriaceae Infections; Kidney; Male; Microbial Sensitivity Tests; Pneumonia, Bacterial; Rats; Rats, Wistar | 1997 |
Quinolone-resistant Salmonella paratyphi B meningitis in a newborn: a case report.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Brain Abscess; Cefotaxime; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Histocytochemistry; Humans; Imipenem; Infant, Newborn; Infant, Premature, Diseases; Meningitis, Bacterial; Microbial Sensitivity Tests; Paratyphoid Fever; Salmonella paratyphi B; Thienamycins; Tomography, X-Ray Computed | 1997 |
Infectious dermatitis in a ball python (Python regius) colony.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Boidae; Cefotaxime; Cephalosporins; Dermatitis; Disease Outbreaks; Fatal Outcome; Female; Male; Proteus Infections; Proteus vulgaris; Pseudomonas aeruginosa; Pseudomonas Infections; Skin Diseases, Infectious | 1998 |
Drug interference in amino acid analysis of urines: a graphic presentation on selected pediatric antibiotics.
Topics: Amikacin; Amino Acids; Ampicillin; Anti-Bacterial Agents; Cefotaxime; Ceftriaxone; Cephalosporins; Chromatography, Ion Exchange; Drug Contamination; Gentamicins; Humans; Infant, Newborn; Tobramycin | 1995 |
Treatment of gram-negative bacterial meningitis in term neonates with third generation cephalosporins plus amikacin.
Topics: Amikacin; Anti-Bacterial Agents; Cefotaxime; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Greece; Humans; Infant, Newborn; Male; Meningitis, Bacterial; Morbidity; Retrospective Studies | 2000 |
Surveillance of antimicrobial resistance in Escherichia coli strains isolated from pigs at Spanish slaughterhouses.
Topics: Abattoirs; Amikacin; Amoxicillin; Animals; Anti-Bacterial Agents; Aztreonam; Cefotaxime; Ceftazidime; Data Collection; Drug Resistance, Microbial; Escherichia coli; Feces; Humans; Imipenem; Microbial Sensitivity Tests; Spain; Sulfonamides; Swine; Tetracycline; Trimethoprim | 2000 |
[The effect of netilmicin, amikacin, ceftazidime and cefotaxime on the adhesive properties of microorganisms isolated from newborn infants].
Topics: Amikacin; Anti-Bacterial Agents; Bacteria; Bacterial Adhesion; Candida albicans; Cefotaxime; Ceftazidime; Cephalosporins; Depression, Chemical; Dose-Response Relationship, Drug; Feces; Gentamicins; Humans; Infant, Newborn; Netilmicin; Respiratory System | 2000 |
Antibiotic susceptibility pattern of Salmonella worthington isolated from neonates--a retrospective study.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Cefotaxime; Chloramphenicol; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Humans; Infant, Newborn; Infant, Newborn, Diseases; Meningitis; Norfloxacin; Penicillins; Prevalence; Retrospective Studies; Salmonella; Salmonella Infections; Sepsis; Time Factors | 2002 |
[Initial antibiotic therapy in maternal-fetal infections which include ampicillin even in countries where listeriosis is an incidental disease].
Topics: Adult; Amikacin; Ampicillin; Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Clinical Protocols; Fatal Outcome; Female; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Listeriosis; Male; Penicillins; Respiratory Distress Syndrome, Newborn | 2002 |
[Endophthalmitis following cataract surgery].
Topics: Amikacin; Cefotaxime; Ceftazidime; Combined Modality Therapy; Drug Therapy, Combination; Endophthalmitis; Follow-Up Studies; Humans; Infusions, Intravenous; Lenses, Intraocular; Postoperative Complications; Prosthesis-Related Infections; Recurrence; Reoperation; Retrospective Studies; Staphylococcal Infections; Vancomycin; Visual Acuity; Vitrectomy | 2002 |
Capillary electrophoresis study of outer membrane proteins of Pseudomonas strains upon antibiotic treatment.
Topics: Amikacin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Cefotaxime; Electrophoresis, Capillary; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections | 2002 |
Nocardial cerebral abscess: report of three cases and review of the current neurosurgical management.
Topics: Adult; Aged; Amikacin; Anti-Bacterial Agents; Brain Abscess; Brain Neoplasms; Cefotaxime; Diagnosis, Differential; Drug Therapy, Combination; Humans; Imipenem; Magnetic Resonance Imaging; Male; Nocardia asteroides; Nocardia Infections; Sulfadiazine; Tomography, X-Ray Computed; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 2003 |
Efficacy of amikacin combinations for nocardiosis.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; beta-Lactams; Cefotaxime; Ciprofloxacin; DNA, Ribosomal; Drug Therapy, Combination; Erythromycin; Female; Fluoroquinolones; Gram-Positive Bacteria; Humans; Imipenem; Lactams; Male; Middle Aged; Minocycline; Nocardia; Nocardia Infections; RNA, Ribosomal, 16S; Streptomyces; Sulfamethoxazole; Trimethoprim | 2003 |
Intratumoral abscess: an unusual complication of ventriculoperitoneal shunt infection.
Topics: Amikacin; Brain Abscess; Cefotaxime; Cerebellar Neoplasms; Child, Preschool; Combined Modality Therapy; Cranial Fossa, Posterior; Cranial Irradiation; Drug Therapy, Combination; Ependymoma; Gram-Negative Bacterial Infections; Humans; Hydrocephalus; Male; Neoplasm, Residual; Postoperative Complications; Prosthesis-Related Infections; Radiotherapy, Adjuvant; Skull Base Neoplasms; Ventriculoperitoneal Shunt | 2004 |
Choroidal abscess due to nocardial infection in a renal allograft recipient.
Topics: Abscess; Amikacin; Amphotericin B; Cefotaxime; Choroid Diseases; Drug Therapy, Combination; Eye Infections, Bacterial; Fluorescein Angiography; Humans; Kidney Transplantation; Male; Middle Aged; Nocardia asteroides; Nocardia Infections; Transplantation, Homologous; Trimethoprim, Sulfamethoxazole Drug Combination; Vitreous Body | 2004 |
[Antibiotic susceptibility and occurrence of ESBL in Pseudomonas aeruginosa strains isolated from different clinical specimens].
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cefotaxime; Ceftazidime; Ciprofloxacin; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Tazobactam; Thienamycins; Ticarcillin | 2004 |
Emergence of Vibrio cholerae O1 Biotype El Tor serotype Inaba in north India.
Topics: Adolescent; Adult; Aged; Amikacin; Anti-Infective Agents; Cefotaxime; Child; Child, Preschool; Cholera; Ciprofloxacin; Disease Outbreaks; Drug Resistance, Bacterial; Female; Gentamicins; Humans; India; Male; Microbial Sensitivity Tests; Middle Aged; Nalidixic Acid; Tetracycline; Trimethoprim; Vibrio cholerae O1 | 2005 |
[Taxonomic spectrum and antibiotic resistance of Enterobacteriaceae isolated from bile of patients with cholangitis].
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Amoxicillin; Anti-Bacterial Agents; Bile; Cefazolin; Cefotaxime; Cholangitis; Chronic Disease; Ciprofloxacin; Drug Resistance, Bacterial; Enterobacteriaceae; Female; Gentamicins; Humans; Male; Middle Aged | 2006 |
[Severe community acquired pneumonia due to Staphylococcus aureus in children. About two cases].
Topics: Amikacin; Anti-Bacterial Agents; Cefotaxime; Child; Child, Preschool; Community-Acquired Infections; Female; Follow-Up Studies; Fosfomycin; Humans; Pneumonia, Staphylococcal; Radiography, Thoracic; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2006 |
Distribution of conjugative-plasmid-mediated 16S rRNA methylase genes among amikacin-resistant Enterobacteriaceae isolates collected in 1995 to 1998 and 2001 to 2006 at a university hospital in South Korea and identification of conjugative plasmids mediat
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Proteins; Cefotaxime; Ciprofloxacin; Conjugation, Genetic; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli Proteins; Hospitals, University; Humans; Korea; Methyltransferases; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction | 2008 |
[Primary Salmonella vascular graft infection and conservative treatment].
Topics: Aged; Amikacin; Anti-Bacterial Agents; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Blood Vessel Prosthesis; Cefotaxime; Ceftriaxone; Combined Modality Therapy; Device Removal; Drug Therapy, Combination; Femoral Artery; Humans; Laparotomy; Male; Ofloxacin; Oxacillin; Popliteal Artery; Prosthesis-Related Infections; Recurrence; Salmonella Infections; Salmonella typhimurium; Shock, Septic | 2008 |
[Epididymo-orchitis and bacteremia caused by Leclercia adecarboxylata].
Topics: Adult; Amikacin; Anti-Bacterial Agents; Bacteremia; Cefotaxime; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Epididymitis; Humans; Male; Microbial Sensitivity Tests; Opportunistic Infections; Orchitis; Paraplegia | 2008 |
Papillon-lefevre syndrome with liver abscess.
Topics: Amikacin; Anti-Bacterial Agents; Cefotaxime; Child; Dermatologic Agents; Humans; Isotretinoin; Liver Abscess; Male; Papillon-Lefevre Disease; Periodontitis; Skin Diseases; Sulbactam | 2009 |
What is the evidence? In horses with septic bursitis for which the organism has not yet been identified, is IV regional perfusion with amikacin or cefotaxime likely to be effective?
Topics: Amikacin; Animals; Anti-Bacterial Agents; Arthritis, Infectious; Bursitis; Cefotaxime; Evidence-Based Practice; Female; Horse Diseases; Horses; Lameness, Animal | 2010 |
Changing trends in newborn sepsis in Sagamu, Nigeria: bacterial aetiology, risk factors and antibiotic susceptibility.
Topics: Amikacin; Anti-Bacterial Agents; Bacteremia; Cefotaxime; Female; Humans; Incidence; Infant, Low Birth Weight; Infant, Newborn; Infant, Newborn, Diseases; Infant, Premature; Male; Microbial Sensitivity Tests; Nigeria; Obstetric Labor Complications; Pregnancy; Prevalence; Prospective Studies; Retrospective Studies; Risk Factors; Socioeconomic Factors | 2011 |
Antimicrobial resistance in more than 100,000 Escherichia coli isolates according to culture site and patient age, gender, and location.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Ampicillin; Anti-Bacterial Agents; Cefotaxime; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Fosfomycin; Humans; Imipenem; Infant; Male; Middle Aged; Nitrofurantoin; Retrospective Studies; Tobramycin; Young Adult | 2011 |
A 6-year-old boy with fever, rash and severe pneumonia.
Topics: Amikacin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefotaxime; Child; Diagnosis, Differential; Drug Therapy, Combination; Fever; Humans; Male; Measles; Pneumonia; Vitamin A | 2012 |
[Dermohypodermitis and gut translocation Escherichia coli septicemia in a newborn infant].
Topics: Abdomen; Amikacin; Amoxicillin; Anti-Bacterial Agents; Bacteremia; Bacterial Translocation; Cefotaxime; Escherichia coli; Escherichia coli Infections; Feces; Female; Fever; Humans; Infant, Newborn; Infant, Newborn, Diseases; Skin Diseases; Thorax; Treatment Outcome | 2013 |
Characteristics of Plasmids Coharboring 16S rRNA Methylases, CTX-M, and Virulence Factors in Escherichia coli and Klebsiella pneumoniae Isolates from Chickens in China.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Bacterial Proteins; Bacteriocin Plasmids; beta-Lactamases; Cefotaxime; Chickens; China; Conjugation, Genetic; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Klebsiella Infections; Klebsiella pneumoniae; Methyltransferases; Microbial Sensitivity Tests; Polymerase Chain Reaction; RNA, Ribosomal, 16S; tRNA Methyltransferases; Virulence Factors | 2015 |
Emergence of Salmonella enterica serovar Indiana and California isolates with concurrent resistance to cefotaxime, amikacin and ciprofloxacin from chickens in China.
Topics: Amikacin; Animals; Anti-Bacterial Agents; beta-Lactamases; Cefotaxime; Chickens; China; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Methyltransferases; Microbial Sensitivity Tests; Multilocus Sequence Typing; Quinolones; RNA, Ribosomal, 16S; Salmonella enterica | 2017 |
Multidrug resistance, prevalence and phylogenetic analysis of genes encoding class II and III integrons in clinically isolated Escherichia coli.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Base Sequence; Cefotaxime; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Gene Expression Regulation, Bacterial; Gentamicins; Hospitals; Humans; Imipenem; Integrons; Microbial Sensitivity Tests; Nalidixic Acid; Ofloxacin; Phylogeny; Polymerase Chain Reaction; Prevalence; Saudi Arabia; Sequence Alignment | 2018 |
Myocardial calcifications following sepsis.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Calcinosis; Cardiomyopathies; Cefotaxime; Female; Humans; Norepinephrine; Sepsis; Treatment Outcome; Vasoconstrictor Agents | 2018 |
PHARMECMO: Therapeutic drug monitoring and adequacy of current dosing regimens of antibiotics in patients on Extracorporeal Life Support.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Cefotaxime; Cilastatin, Imipenem Drug Combination; Coronary Care Units; Drug Monitoring; Extracorporeal Membrane Oxygenation; Female; Gentamicins; Humans; Male; Middle Aged; Pilot Projects; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Sepsis; Tobramycin | 2019 |
Molecular-diversity, Prevalence and Antibiotic Susceptibility of Pathogenic Klebsiella Pneumoniae under Saudi Condition.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cefotaxime; Ceftazidime; Ceftriaxone; DNA, Bacterial; Female; Genetic Variation; Genotype; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Polymerase Chain Reaction; Prevalence; Saudi Arabia; Virulence | 2019 |
Genotypic resistance determined by whole genome sequencing versus phenotypic resistance in 234 Escherichia coli isolates.
Topics: Amikacin; Amoxicillin; Anti-Bacterial Agents; Cefepime; Cefotaxime; Ceftazidime; Ciprofloxacin; Clavulanic Acid; Escherichia coli; Escherichia coli Infections; Genotype; Gentamicins; Humans; Meropenem; Microbial Sensitivity Tests; Phenotype; Piperacillin; Retrospective Studies; Tazobactam; Tobramycin; Whole Genome Sequencing | 2023 |
In vitro and in vivo evaluation of DNase I in reinstating antibiotic efficacy against Klebsiella pneumoniae biofilms.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Biofilms; Cattle; Cefotaxime; Ciprofloxacin; Deoxyribonuclease I; Disease Models, Animal; Klebsiella pneumoniae; Mice; Microbial Sensitivity Tests | 2023 |
[The Importance of Gram-stained Smears in the Diagnosis of Nocardia Infections].
Topics: Amikacin; Anti-Bacterial Agents; Cefepime; Cefotaxime; Ceftriaxone; Ciprofloxacin; Clarithromycin; Humans; Imipenem; Linezolid; Nocardia; Nocardia Infections; RNA, Ribosomal, 16S; Trimethoprim, Sulfamethoxazole Drug Combination | 2023 |
Cefotaxime/sulbactam plus gentamicin as a potential carbapenem- and amikacin-sparing first-line combination for neonatal sepsis in high ESBL prevalence settings.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefotaxime; Escherichia coli; Gentamicins; Humans; Infant, Newborn; Microbial Sensitivity Tests; Neonatal Sepsis; Prevalence; Sulbactam | 2023 |